Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABAC

Renmin Tianli Group (ABAC) Stock Price, News & Analysis

About Renmin Tianli Group Stock (NASDAQ:ABAC)

Advanced Chart

Key Stats

Today's Range
$0.69
$0.69
50-Day Range
$0.69
$2.15
52-Week Range
$0.85
$3.39
Volume
N/A
Average Volume
111,552 shs
Market Capitalization
$6.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renmin Tianli Group and its competitors with MarketBeat's FREE daily newsletter.

ABAC Stock News Headlines

Tianli Holdings Group Ltd (0117)
Tianli Holdings Group Limited (0117.HK)
A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Is the Russell Group still relevant?
See More Headlines

ABAC Stock Analysis - Frequently Asked Questions

Renmin Tianli Group, Inc. (NASDAQ:ABAC) released its quarterly earnings results on Thursday, August, 11th. The basic materials company reported $0.02 earnings per share for the quarter. The basic materials company earned $9.61 million during the quarter, compared to the consensus estimate of $9.85 million. Renmin Tianli Group had a negative trailing twelve-month return on equity of 0.35% and a negative net margin of 8.18%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Renmin Tianli Group investors own include Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Ampliphi Biosciences (APHB), Mastech Digital (MHH), Senseonics (SENS), Abeona Therapeutics (ABEO) and ARCA biopharma (ABIO).

Company Calendar

Last Earnings
8/11/2016
Today
8/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Agricultural Production - Livestock & Animal Specialties
Sub-Industry
N/A
Current Symbol
NASDAQ:ABAC
CIK
1486299
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.10 million
Net Margins
-8.18%
Pretax Margin
N/A
Return on Equity
-0.35%
Return on Assets
-0.33%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.57
Quick Ratio
18.06

Sales & Book Value

Annual Sales
$27 million
Price / Sales
0.26
Cash Flow
$0.21 per share
Price / Cash Flow
3.27
Book Value
$11.34 per share
Price / Book
0.06

Miscellaneous

Outstanding Shares
10,030,000
Free Float
N/A
Market Cap
$6.92 million
Optionable
Not Optionable
Beta
2.01
10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ABAC) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners